These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 29501282

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Feasibility of lactadherin-bearing clinically available microbubbles as ultrasound contrast agent for angiogenesis.
    Otani K, Yamahara K.
    Mol Imaging Biol; 2013 Oct; 15(5):534-41. PubMed ID: 23539172
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of tumor imaging with microbubble-based ultrasound contrast agent, sonazoid, in rabbit liver.
    Watanabe R, Matsumura M, Chen CJ, Kaneda Y, Fujimaki M.
    Biol Pharm Bull; 2005 Jun; 28(6):972-7. PubMed ID: 15930729
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo.
    Hu Q, Wang XY, Kang LK, Wei HM, Xu CM, Wang T, Wen ZH.
    PLoS One; 2016 Jun; 11(2):e0149075. PubMed ID: 26862757
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enhancement of ovarian tumor detection with αvβ3 integrin-targeted ultrasound molecular imaging agent in laying hens: a preclinical model of spontaneous ovarian cancer.
    Barua A, Yellapa A, Bahr JM, Machado SA, Bitterman P, Basu S, Sharma S, Abramowicz JS.
    Int J Gynecol Cancer; 2014 Jan; 24(1):19-28. PubMed ID: 24304684
    [Abstract] [Full Text] [Related]

  • 17. Real-time imaging of the lymphatic channels and sentinel lymph nodes of the stomach using contrast-enhanced ultrasonography with Sonazoid in a porcine model.
    Kawai Y, Ajima K, Nagai T, Kaidoh M, Ohhashi T.
    Cancer Sci; 2011 Nov; 102(11):2073-81. PubMed ID: 21797945
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.
    Warram JM, Sorace AG, Saini R, Umphrey HR, Zinn KR, Hoyt K.
    J Ultrasound Med; 2011 Jul; 30(7):921-31. PubMed ID: 21705725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.